ICD-10-CM Billable Code

E28.1

Androgen excess

Clinical Classification Guidelines

Use Additional Code

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Inclusion Terms

  • Hypersecretion of ovarian androgens

Medical Intelligence & Overview

Androgen excess, classified under ICD-10 code E28.1, refers to a condition characterized by an overproduction of androgens, which are often considered male hormones but are also naturally present in females. This hypersecretion predominantly involves ovarian androgens, leading to various health issues in women. Recognizing the causes, symptoms, and treatment options can help in managing this condition effectively.

Causes & Symptoms

Clinical Causes: Polycystic ovary syndrome (PCOS): A common endocrine disorder that often results in excess androgen production. Ovarian tumors: Certain benign or malignant tumors in the ovaries can produce excess androgens. Adrenal gland disorders: Conditions like adrenal hyperplasia or tumors can elevate androgen levels. Medications: Use of certain drugs that interfere with hormonal balance may contribute to androgen excess. Genetic factors: Inherited conditions causing enzyme deficiencies affecting hormone synthesis.

Key Symptoms: Hirsutism: Excessive hair growth on the face, chest, or back. Acne: Increased severity or persistence of acne in women. Irregular menstrual cycles: Abnormal menstruation, including missed or infrequent periods. Male-pattern baldness: Thinning or loss of scalp hair. Deepening of the voice: In some cases, voice may become more masculine. Weight gain: Particularly around the abdomen and face. Skin changes: Oily skin or development of dark patches. Infertility: Difficulties in conceiving due to hormonal imbalance.

Diagnostic & Treatment

Diagnosis Path: Diagnosing androgen excess involves a combination of medical history review, physical examination, and laboratory tests. Blood tests measure androgen hormone levels, including testosterone and dehydroepiandrosterone sulfate (DHEAS). Imaging studies like ultrasound or MRI may be used to examine the ovaries or adrenal glands for tumors or cysts. Additional assessments might include evaluating menstrual patterns and signs of hyperandrogenism.

Treatment Protocols: Lifestyle modifications: Weight management and healthy diet to reduce symptoms. Medications: Birth control pills to regulate menstrual cycles and reduce androgen levels. Anti-androgens: Drugs like spironolactone that decrease the effects of androgens. Treating underlying conditions: Surgery or medications for ovarian tumors or adrenal issues. Fertility treatments: If pregnancy is desired, specific therapies may be recommended depending on the cause. Monitoring: Regular follow-up with healthcare providers to track hormone levels and symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E28.1 a billable ICD-10 code?
Yes, E28.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E28.1?
Clinical documentation must specify the nature of Androgen excess and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

androgen excess